Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ADCT ADC Therapeutics SA Common Shares | 0.98 USD | -1.01% | -7.55% | -16.24% | -69.18% | 125.11 M USD | ||
| 3857 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.68 USD | 0.00% | +12.77% | +36.44% | -46.64% | 121.38 M USD | ||
| 3859 |  VANI Vivani Medical, Inc. - Common Stock | 1.37 USD | -0.72% | +0.74% | +5.38% | +10.48% | 123.58 M USD | ||
| 3864 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +10.13% | +6.10% | +40.32% | 121.27 M USD | ||
| 3869 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.70 USD | -0.27% | +9.79% | -0.27% | +22.52% | 125.89 M USD | ||
| 3872 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.65 USD | +20.44% | +20.44% | +30.95% | -10.81% | 119.60 M USD | ||
| 3873 |  GUTS Fractyl Health, Inc. - Common Stock | 0.75 USD | -3.85% | +8.70% | -5.06% | -25.00% | 119.38 M USD | ||
| 3875 |  GNLX Genelux Corporation - Common Stock | 2.63 USD | -3.31% | -1.50% | -11.15% | -30.24% | 119.00 M USD | ||
| 3879 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.80 USD | +1.12% | +4.65% | -2.70% | -78.57% | 120.58 M USD | ||
| 3889 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.92 USD | +1.03% | +4.24% | +13.63% | -31.19% | 115.41 M USD | ||
| 3892 |  SEER Seer, Inc. - Class A Common Stock | 2.06 USD | +1.48% | +0.98% | +4.04% | -0.96% | 114.07 M USD | ||
| 3896 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.89 USD | -6.32% | -2.20% | -47.95% | +27.14% | 113.26 M USD | ||
| 3920 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.83 USD | -1.19% | -2.35% | +3.75% | -17.82% | 105.83 M USD | ||
| 3956 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.91 USD | +1.39% | +2.46% | -13.39% | +27.63% | 97.05 M USD | ||
| 3959 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.12 USD | -0.72% | +1.73% | +9.87% | -59.73% | 98.08 M USD | ||
| 3961 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.43 USD | -2.78% | +14.16% | +17.00% | -36.07% | 94.66 M USD | ||
| 3971 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.20 USD | -0.45% | +11.68% | +35.80% | +64.18% | 94.28 M USD | ||
| 3975 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.15 USD | +0.98% | +6.19% | +30.38% | +49.28% | 93.75 M USD | ||
| 3978 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +4.26% | -68.99% | 93.19 M USD | ||
| 3980 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.54 USD | +1.32% | -1.28% | +0.65% | -73.54% | 92.90 M USD |
Notizie Biotechnology Stocks
Il titolo azionario di Alto Neuroscience raggiunge il massimo storico a 35,42 USD
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |